News

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

eCOA Consortium Announces Next Article in a Series for Applied Clinical Trials

C-Path’s eCOA Consortium is pleased to announce that “Progressing BYOD Adoption” has been published in Applied Clinical Tria

June 8, 2022

PRO Consortium Announces Publication of Open Access Article

C-Path’s PRO Consortium is pleased to announce that “Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ)

April 2, 2022

eCOA Consortium and PRO Consortium Announce Publication of Open Access Article

C-Path’s eCOA Consortium and PRO Consortium are pleased to announce that “Recommendations for the Electronic Migration and

Doctor With Rare Disease And No Answers Decides To Find His Own Cure

Castleman’s Disease: Behind the Mystery of Rare Disease

New logo! Rare Disease Cures Accelerator-Data and Analytics Platform has a new look!

C-Path’s RDCA-DAP team is excited to unveil its new logo for the Rare Disease Cures Accelerator-Data and Analytics Platform

C-Path is proud to share our responses to the FDA draft guidance, Digital Health Technologies for Remote Data Acquisition in Clinical Investigations

The Clinical Outcomes Assessment (COA), Critical Path for Parkinson’s Digital Drug Development (3DT) Initiative, and Type 1 Diab

March 21, 2022

Recommendations to Optimize the Use of Volumetric MRI in Huntington’s Disease in Clinical Trials

C-Path’s Huntington’s Disease Regulatory Science Consortium (HD-RSC) has published a new paper on volumetric MRI-based biomark

C-Path Welcomes ActiGraph

C-Path is proud to welcome ActiGraph as the newest member of its Electronic Clinical Outcome Assessment (eCOA) Consortium. Compr

eCOA Consortium Announces Publication of Open Access Article

C-Path’s eCOA Consortium is pleased to announce that “Measurement Comparability of Electronic and Paper Administration of Vi

Previous1314 15...31 Next